| Literature DB >> 34961915 |
Bagher Larijani1, Shayesteh Kokabi Hamidpour2, Akram Tayanloo-Beik2, Ainaz Shahbazbadr2, Hanieh Yavari2, Nazli Namazi3, Mahmood Biglar1, Babak Arjmand4.
Abstract
Animal studies are recognized as a significant step forward in the bridging between drug discovery and clinical applications. Animal models, due to their relative genetic, molecular, physiological, and even anatomical similarities to humans, can provide a suitable platform for unraveling the mechanisms underlying human diseases and discovering new therapeutic approaches as well. Recently, zebrafish has attracted attention as a valuable experimental and pharmacological model in drug discovery and development studies due to its prominent characteristics such as the high degree of genetic similarity with humans, genetic manipulability, and prominent clinical features. Since advancing a theory to a valid and reliable observation requires the manipulation of animals, it is, therefore, essential to use efficient modeling methods appropriate to the different aspects of experimental conditions. In this context, applying several various approaches such as using chemicals, pathogens, and genetic manipulation approaches allows zebrafish development into a preferable model that mimics some human disease pathophysiology. Thus, such modeling approaches not only can provide a framework for a comprehensive understanding of the human disease mechanisms that have a counterpart in zebrafish but also can pave the way for discovering new drugs that are accompanied by higher amelioration effects on different human diseases.Entities:
Keywords: Animal modeling; Danio rerio; Drug development; Drug discovery; In vivo studies; Zebrafish
Mesh:
Year: 2022 PMID: 34961915 DOI: 10.1007/5584_2021_684
Source DB: PubMed Journal: Adv Exp Med Biol ISSN: 0065-2598 Impact factor: 3.650